The Cancer Moonshot: Increasing cancer survivorship for everyone

With the goal of cutting cancer deaths in half by 2047, the White House's Cancer Moonshot initiative is pumping $1.8 billion into cancer research over the next seven years. Achieving this goal, however, will require clearing research hurdles — including the lack of diversity in clinical trials, say Richard Barakat, MD, and David Tuveson, MD, PhD. They discuss the exciting research being funded by the Moonshot initiative, describe efforts to improve and diversify clinical trial recruitment, and explain the fruitful collaboration between Northwell Health and Cold Spring Harbor. Chapters: 01:33 - What is the Cancer Moonshot? 02:16 - Replicating success, speed of Covid-19 vaccine development 03:46 - Allocating funds 06:41 - The pre-neoplasia project 09:48 - Pushing for greater access 11:23 - Cancer disparities, outcomes 12:55 - Community outreach is critical 14:25 - Commitment to cancer research 16:26 - Practice changing, paradigm shifting, policy making 19:30 - Can we cut mortality by 50 percent?  Meet the experts Richard Barakat, MD, Physician-in-Chief and Director of Cancer, Northwell Cancer Institute David Tuveson, MD, PhD, Professor, Director, Cancer Center, Cold Spring Harbor Watch episodes of 20-Minute Health Talk on YouTube.